Form 4: CONMED Director Mark Kaye Converts RSUs to Shares

CONMED Director Mark Kaye acquired 152 shares of common stock through the vesting of Restricted Stock Units.

Summary

• Mark Kaye, a Director of CONMED Corp (CNMD), acquired 152 shares of common stock.
• This acquisition resulted from the vesting of 152 Restricted Stock Units (RSUs).
• The transaction occurred on February 24, 2026, with a reported acquisition price of $0 per share.
• The RSUs were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan.
• RSUs generally vest 100% after a one-year period or immediately upon termination of the Director's service.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a routine, slightly positive event. The vesting of RSUs and subsequent acquisition of shares by a director is an expected part of executive compensation, demonstrating continued alignment of insider interests with shareholder value.

Positives

• Director Mark Kaye increased his direct ownership in CONMED Corp by 152 shares, aligning his interests further with shareholders.
• The transaction represents a planned compensation event, indicating the successful vesting of previously granted equity awards.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those related to equity compensation vesting, are common across industries. This specific filing reflects a standard practice for compensating non-employee directors with equity, aligning their long-term interests with company performance.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) for non-employee director compensation is a common practice among publicly traded companies, including peers in the medical technology sector like Stryker Corporation (SYK) or Zimmer Biomet Holdings (ZBH), which also utilize equity awards to incentivize long-term commitment and align director interests with shareholder value.
• The vesting schedule (100% after one year or upon termination) is typical for director equity awards, designed to retain directors and reward service.

Corporate Governance

Stakeholder Impact

• Shareholders: Increased direct ownership by a director can be seen as a positive signal of confidence and alignment of interests.

Key Dates

Recommendation

This Form 4 filing reports a routine insider transaction involving the vesting of Restricted Stock Units for a director. While it shows continued insider ownership, it does not provide new fundamental information about the company's financial performance, strategic direction, or significant operational changes that would warrant a change in investment recommendation. It's an expected compensation event.

Keywords

CONMED Corp, CNMD, Mark Kaye, Director, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Equity Compensation, Share Acquisition